The treatment of rosacea: Clonidine (0.075 mg/j) versus placebo. Preliminary results [2];Traitement de la rosacee: Clonidine (0.075 mg/j) versus placebo (resultats preliminaires)

Annales de Dermatologie et de Venereologie

Volumn 124, Issue 10, 1997, Pages 729-

  Van Landuyt, H ^a   Joubert Lequain, I ^a   Humbert, P ^a   Lucas, A ^a   Drobacheff, C ^a   Mercier, M ^a   Laurent, R ^a  

^a HÔPITAL SAINT JACQUES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; MINOCYCLINE; PLACEBO; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ERYTHEMA; HUMAN; LETTER; PAPULE; PHASE 3 CLINICAL TRIAL; PUSTULE; RANDOMIZED CONTROLLED TRIAL; ROSACEA;

ADRENERGIC ALPHA-AGONISTS; CLONIDINE; HUMANS; PLACEBOS; ROSACEA;

EID: 0031311247     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)